Page last updated: 2024-11-03

procarbazine and Agnogenic Myeloid Metaplasia

procarbazine has been researched along with Agnogenic Myeloid Metaplasia in 7 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research Excerpts

ExcerptRelevanceReference
"Four patients with Hodgkin's disease and bone marrow fibrosis are presented in whom the clinical presentation was dominated by cytopenias; this was associated with a delayed diagnosis for an average of 20 months."1.28Hodgkin's disease presenting as myelofibrosis. ( Crawford, J; Kaufman, RE; Laszlo, J; Meadows, LM; Moore, JO; Rosse, WR, 1989)
"Malignant myelosclerosis or acute myelofibrosis is a rare acute myeloproliferative disorder characterized by pancytopenia, myeloblastosis and marrow fibrosis."1.26Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy. ( Ali, NO; Janes, WO, 1979)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kueh, YK1
Tan, YO1
Sng, I1
Rauff, A1
Ali, NO1
Janes, WO1
Meadows, LM1
Rosse, WR1
Moore, JO1
Crawford, J1
Laszlo, J1
Kaufman, RE1
Carroll, WL1
Berberich, FR1
Glader, BE1
Young, RC1
Canellos, GP1
Chabner, BA1
Schein, PS1
DeVita, VT1
Pinedo, HM1
Van Hemel, JO1
Vrede, MA1
Van der Sluys Veer, J1
Viola, MV1
Kovi, J1
Nukhopadhyay, M1

Trials

1 trial available for procarbazine and Agnogenic Myeloid Metaplasia

ArticleYear
Maintenance chemotherapy for advanced Hodgkin's disease in remission.
    Lancet (London, England), 1973, Jun-16, Volume: 1, Issue:7816

    Topics: Blood Cell Count; Blood Platelets; Hodgkin Disease; Humans; Lymphocytes; Mechlorethamine; Nitrosoure

1973

Other Studies

6 other studies available for procarbazine and Agnogenic Myeloid Metaplasia

ArticleYear
Reversal of red cell aplasia and marrow fibrosis in non-Hodgkin's lymphoma.
    Annals of the Academy of Medicine, Singapore, 1983, Volume: 12, Issue:3

    Topics: Adult; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; L

1983
Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy.
    Cancer, 1979, Volume: 43, Issue:4

    Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Glom

1979
Hodgkin's disease presenting as myelofibrosis.
    Cancer, 1989, Oct-15, Volume: 64, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Diagnosis, Differential; Female;

1989
Pancytopenia with myelofibrosis. An unusual presentation of childhood Hodgkin's disease.
    Clinical pediatrics, 1986, Volume: 25, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Female; Hodgkin Disease; Humans;

1986
Letter: Acute myelofibrosis and chromosome damage after procarbazine treatment.
    British medical journal, 1974, Aug-24, Volume: 3, Issue:5929

    Topics: Aged; Aging; Aneuploidy; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Humans; Male; Penil

1974
Reversal of myelofibrosis in Hodgkin disease.
    JAMA, 1973, Mar-05, Volume: 223, Issue:10

    Topics: Adult; Anemia, Aplastic; Biopsy, Needle; Cyclophosphamide; Female; Hodgkin Disease; Humans; Predniso

1973